Formulation and Stability of a 1% Clarithromycin-Based Topical Skin Cream: A New Option to Treat Buruli Ulcers?

Sebti M, Schweitzer-Chaput A, Cisternino S, Hinterlang M, Ancedy D, Lam S, Auvity S, Cotteret C, Lortholary O, Schlatter J

Open source

DOI
10.3390/ph17060691
Published
2024 May 27
Container
Pharmaceuticals (Basel, Switzerland)
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/ph17060691,
  title = {Formulation and Stability of a 1\% Clarithromycin-Based Topical Skin Cream: A New Option to Treat Buruli Ulcers?},
  author = {Sebti M and Schweitzer-Chaput A and Cisternino S and Hinterlang M and Ancedy D and Lam S and Auvity S and Cotteret C and Lortholary O and Schlatter J},
  year = {2024},
  journal = {Pharmaceuticals (Basel, Switzerland)},
  doi = {10.3390/ph17060691},
  url = {https://doi.org/10.3390/ph17060691}
}

RIS

TY  - JOUR
TI  - Formulation and Stability of a 1% Clarithromycin-Based Topical Skin Cream: A New Option to Treat Buruli Ulcers?
AU  - Sebti M
AU  - Schweitzer-Chaput A
AU  - Cisternino S
AU  - Hinterlang M
AU  - Ancedy D
AU  - Lam S
AU  - Auvity S
AU  - Cotteret C
AU  - Lortholary O
AU  - Schlatter J
PY  - 2024
JO  - Pharmaceuticals (Basel, Switzerland)
DO  - 10.3390/ph17060691
UR  - https://doi.org/10.3390/ph17060691
ER  - 

APA

M, S., A, S., S, C., M, H., D, A., S, L., S, A., C, C., O, L., & J, S. (2024). Formulation and Stability of a 1% Clarithromycin-Based Topical Skin Cream: A New Option to Treat Buruli Ulcers?. Pharmaceuticals (Basel, Switzerland). https://doi.org/10.3390/ph17060691

Source records